E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Under the agreement, AstraZeneca has acquired worldwide rights to develop and commercialise Zegfrovy.
imphoenix82
On the current trajectory, blood cancer therapies are expected to add 18.9 million life-years from 2026 to 2040.
imphoenix82
BTL’s proprietary technology combines multiple erbium laser wavelengths into a single beam, aiming to set a new standard in laser-based facial rejuvenation.
imphoenix82
The new Digital Training Hub is expected to support approximately 200 eye health professionals annually across Karnataka and South India, with a focus on medical retina training for ophthalmologists.
imphoenix82
The CCI approval clears a key regulatory step for the proposed transaction, which will bring Apollo Fertility Centre and Specialty Hospitals under KCIL’s ownership.
imphoenix82
Under the new partnerships, Medtronic will have rights to distribute Cornerstone Robotics’ Sentire surgical system in select markets outside the US and is expected to become the exclusive global commercial distributor of Pi-Cardia’s ShortCut device in 2027.
imphoenix82
The acquisition of eCential Robotics is expected to strengthen and expand Enovis’ ASTRA enabling technology ecosystem by adding robotic automation capabilities.
imphoenix82
To streamline the international patient journey, Yashoda Medicity and Turkistan will explore coordination for visas, appointments and admissions, subject to applicable laws.
imphoenix82
Under its agreement with the US government, Sun Pharma will extend Most Favoured Nation (MFN) pricing to state Medicaid programmes and apply MFN pricing to future innovative medicine launches.
imphoenix82
GSK’s investigational mRNA seasonal flu vaccine is designed to target both haemagglutinin (HA) and neuraminidase (NA), the primary surface antigens that cause the flu virus to bind and spread.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
